Keyword search (4,164 papers available)

"Phenotype" Keyword-tagged Publications:

Title Authors PubMed ID
1 Efficacy of cognitive behavioral therapy for insomnia and lemborexant medication for different subtypes of chronic insomnia: study protocol for a randomized controlled trial Chen SJ; Ivers H; Dang-Vu TT; Shapiro CM; Carney CE; Robillard R; Morin CM; 40346496
HKAP
2 A multimodal neuroimaging study of youth at risk for substance use disorders: Functional magnetic resonance imaging and [18F]fallypride positron emission tomography Nikolic M; Cox SML; Jaworska N; Castellanos-Ryan N; Dagher A; Vitaro F; Brendgen M; Parent S; Boivin M; Côté S; Tremblay RE; Séguin JR; Leyton M; 39725679
CSBN
3 Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities Samuel Olajide T; Oyerinde TO; Omotosho OI; Okeowo OM; Olajide OJ; Ijomone OM; 39364217
PSYCHOLOGY
4 Body-composition phenotypes and their associations with cardiometabolic risks and health behaviours in a representative general US sample Kakinami L; Plummer S; Cohen TR; Santosa S; Murphy J; 36183799
PERFORM
5 Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial. Tuiten A, Michiels F, Böcker KB, Höhle D, van Honk J, de Lange RP, van Rooij K, Kessels R, Bloemers J, Gerritsen J, Janssen P, de Leede L, Meyer JJ, Everaerd W, Frijlink HW, Koppeschaar HP, Olivier B, Pfaus JG 30016917
CSBN

 

Title:Body-composition phenotypes and their associations with cardiometabolic risks and health behaviours in a representative general US sample
Authors:Kakinami LPlummer SCohen TRSantosa SMurphy J
Link:https://pubmed.ncbi.nlm.nih.gov/36183799/
DOI:10.1016/j.ypmed.2022.107282
Publication:Preventive medicine
Keywords:Body compositionCardiometabolic riskEpidemiologyNHANESPhenotype
PMID:36183799 Category: Date Added:2022-10-03
Dept Affiliation: PERFORM
1 Department of Mathematics and Statistics, Concordia University, Montreal, Quebec, Canada; PERFORM Centre, Concordia University, Montreal, Quebec, Canada. Electronic address: lisa.kakinami@concordia.ca.
2 Department of Chemistry, Concordia University, Montreal, Quebec, Canada.
3 Faculty of Land and Food Systems, Food, Nutrition and Health, University of British Columbia, Vancouver, British Columbia, Canada.
4 PERFORM Centre, Concordia University, Montreal, Quebec, Canada; Department of Health, Kinesiology, and Applied Physiology, Concordia University, Montreal, Quebec, Canada; Metabolism, Obesity, Nutrition Lab, PERFORM Centre, Concordia University, Montreal, Quebec, Canada.
5 Department of Health, Kinesiology, and Applied Physiology, Concordia University, Montreal, Quebec, Canada; Metabolism, Obesity, Nutrition Lab, PERFORM Centre, Concordia University, Montreal, Quebec, Canada.

Description:

Body mass index is poor at distinguishing between adiposity and muscle. Based on dual energy X-ray absorptiometry data, a diagnostic framework to analyze body composition by categorizing fat- and muscle-mass body composition into four phenotypes has been proposed. The objective of this study was to assess the association between body-composition phenotypes with adiposity measures, health behaviours and cardiometabolic risks in a representative U.S. adult population. Data were from NHANES (1999-2006: n = 9867; 2011-2018: n = 10,454). Four phenotypes based on being above/below the 50th percentile of age- and sex- adjusted reference curves of fat-mass and muscle-mass were identified. Multiple linear and logistic regressions were used to assess phenotypes (high [H] or low [L] adiposity [A] or muscle mass [M]) against adiposity measures, health behaviours, cardiometabolic risk, and dietary intake. Low-adiposity/high-muscle (LA-HM) was the referent. Analyses incorporated the complex sampling design and survey weights, and were adjusted for age, sex, race, and education. Compared to the LA-HM reference group, the HA-LM phenotype was less physically active, had higher total and lower high-density lipoprotein cholesterol, and had lower intake of all examined nutrients (all p < 0.01). For the HA-HM phenotype, unfavourable values were detected for all adiposity and cardiometabolic measures compared to the LA-HM phenotype (all p < 0.01). The two high adiposity phenotypes were associated with poorer health behaviours and cardiovascular risk factors, regardless of muscle-mass, but associations differed across the phenotypes. Results further underscores the importance of accounting for both adiposity and muscle mass in measurement and analysis. Further longitudinal investigation is needed.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University